ArisGlobal Strengths, Domain Expertise, and Key Differentiators
ArisGlobal is a visionary technology company that’s transforming the way today’s most successful life sciences companies develop breakthroughs and bring new products to market.
The ArisGlobal LifeSphere cognitive technology platform integrates machine-learning capabilities to automate the core functions of the product lifecycle. Designed with deep expertise and a long-term perspective that spans more than 30 years, their cognitive platform delivers actionable insights, boosts efficiency, ensures compliance, and lowers total cost of ownership through multi-tenancy.
Risk Management, a key solution within LifeSphere Safety, the multi-tenant cloud Pharmacovigilance and Safety platform suite, delivers significant improvements including:
- Smarter signal detection algorithms to reduce noise-to-signal ratio. - End-to-end workflow to streamline signal detection, signal management and risk management planning activities and to capture the full range of decisions from identification to actions. - A user-friendly graphical interface supported by advanced analytics, visualization and computational engine. - Comprehensive reporting capabilities to support regulatory and business requirements including Compliance, Inspections, PBRER and KPI. - Ability to capture and analyze social media sentiment through natural language processes for comprehensive analysis LifeSphere Safety – Risk Management is aligned with ArisGlobal’s overall LifeSphere® vision that is based on providing multi-tenancy cloud deployment, an open and integrated architecture, solutions based on industry standard practices, and the delivery of advanced automation capabilities.
ArisGlobal Recent Developments
In December 2023, ArisGlobal unveiled LifeSphere NavaX, a state-of-the-art cognitive computing engine designed to accelerate the digitization of R&D IT processes. Leveraging cutting-edge technologies such as Large Language Models and Generative AI, this platform represents a significant advancement in research and development capabilities. In 2018, ArisGlobal introduced LifeSphere MultiVigilance, a pioneering platform for individual case study safety report intake. Initially powered by LifeSphere Nava (v1), this platform integrated advanced robotic process automation and cognitive computing technologies, including natural language processing and machine learning, to revolutionize pharmacovigilance operations.
In June 2020, ArisGlobal launched LifeSphere Regulatory, an all-new cloud platform that addresses the full end-to-end regulatory management process in a simple, unified suite. The new LifeSphere Regulatory platform includes LifeSphere RIMS, a complete solution for managing all core regulatory processes, and LifeSphere Publishing, a submissions management system that enables life science organizations to easily compile, publish, and validate regulatory submissions with full support for all major global eCTD requirements. LifeSphere Regulatory is also integrated with LifeSphere EasyDocs, a modern cloud document management platform that enables a single source of truth for data and documents across R&D business processes.
ArisGlobal Mergers and Acquisitions (M&A) Activities
In 2023, ArisGlobal executed three strategic acquisitions. In May, ArisGlobal finalized the acquisition of SPORIFY, a data governance and integration solution focusing on Substances, Products, Organizations, and Referentials (SPOR). SPORIFY ensures the provision of consistent and ISO IDMP-compliant SPOR data, crucial for regulatory activities throughout the product life cycle. This integration into the LifeSphere platform enhances IDMP-compliant LifeSphere RIMS implementations, establishing proactive data governance processes prior to health authority submissions, thereby facilitating more informed regulatory decisions aimed at advancing public health and safety.
In April, ArisGlobal acquired Amplexor Life Sciences, a leading technology company in drug development. This strategic move aims to provide a comprehensive and intelligent regulatory platform, enhancing efficiency for life sciences organizations in bringing new therapies to market.
In February, ArisGlobal completed the acquisition of Amplexor Life Sciences, a globally recognized provider of regulatory, quality, and safety software solutions catering to pharmaceutical, biotechnology, and medical device firms. The integration of regulatory product lines promises a myriad of benefits for customers, including enhanced publishing and labeling capabilities, as well as access to a robust Quality Management System from Amplexor LS, thereby bolstering the value proposition for LifeSphere users.
ArisGlobal Customers in ARTW Customer Database
Leveraging a rigorous data-centric research methodology, APPS RUN THE WORLD asks the simple question: Who’s buying ArisGlobal applications and why? And we provide the answers – supported by decades of research – to our clients around the world. Our Customer database has over 100 data fields that detail company usage of ArisGlobal and other enterprise apps by function, customer size, industry, location, implementation status, partner involvement, Line of Business Key Stakeholders and IT decision makers contact details. List of Verified ArisGlobal LifeSphere Platform customers.
ArisGlobal Overview
201 Jones Road, 3rd FL East
Waltham, MA, 2451, United States
1 609-360-4042
https://www.arisglobal.com/
Ownership: - Nordic Capital
Number of Employees: 2100
Functional Markets: Content Management, ERP Services and Operations, PLM, PPM, TRM,
Key Verticals: Life Sciences,
ArisGlobal Key Enterprise and Cloud Applications
ArisGlobal LifeSphere Platform
ArisGlobal Revenues, $M:
| Type/Year | 2022 | 2023 | YoY Growth, % |
|---|---|---|---|
| Total Revenues, $M | Subscribe | Subscribe | Subscribe |
| Enterprise Applications Revenues, $M | Subscribe | Subscribe | Subscribe |
| Cloud Applications Revenues, $M | Subscribe | Subscribe | Subscribe |
* Enterprise Applications Revenues = License + Support & Maintenance + SaaS
** All revenue figures are estimates based on public records, Cloud and Non-Cloud business models in Apps Run The World's vendor database, and annual survey results including vendor feedback.
ArisGlobal Revenue Breakdown By Type, $M:
ArisGlobal Enterprise Applications Revenues By Functional Markets, $M:
ArisGlobal Enterprise Applications Revenues By Verticals, $M:
ArisGlobal Revenues By Region, $M
| Region | % of Total Revenues | 2023 Total Revenues, $M | 2023 Enterprise Applications Revenues, $M | 2023 Cloud Applications Revenues, $M |
|---|---|---|---|---|
| Americas | Subscribe | Subscribe | Subscribe | Subscribe |
| EMEA | Subscribe | Subscribe | Subscribe | Subscribe |
| APAC | Subscribe | Subscribe | Subscribe | Subscribe |
| Total | Subscribe | Subscribe | Subscribe | Subscribe |
ArisGlobal Direct vs Indirect sales
| Region | Direct Sales | Indirect Sales | Total |
|---|---|---|---|
| Type % | Subscribe | Subscribe | Subscribe |
| Revenues, $M | Subscribe | Subscribe | Subscribe |
ArisGlobal Customers - Breakdown by Geo, Size, Vertical and Product
List of Verified ArisGlobal Customers
No. of ArisGlobal Customers: 500
No. of ArisGlobal Enterprise Applications Customers: 500
No. of ArisGlobal Cloud Customers: x
No. of ArisGlobal Cloud Subscribers: x
ArisGlobal is the trusted partner for over 500 life science companies worldwide, providing essential solutions to streamline regulatory compliance, mitigate risks, and enhance operational effectiveness.
Notable among ArisGlobal's esteemed clientele are prominent organizations such as SPIMACO, Seikagaku Corporation, Linde Healthcare, Merz Pharmaceuticals, Dohmen Life Science Services (DLSS), AstraZeneca, SIRO Clinpharm, China FDA Center of Drug Evaluation, and numerous others.
ArisGlobal Market Opportunities, M&A and Geo Expansions
In early 2023, ArisGlobal officially introduces the commercial release of LifeSphere Clarity. This product represents a significant enhancement to the extensive LifeSphere platform and serves as a cornerstone within the data & analytics product portfolio. LifeSphere Clarity empowers research and development entities to swiftly identify risks and extract insights, thereby addressing signal issues in clinical trials and post-marketing scenarios with greater efficiency. By leveraging LifeSphere Clarity, organizations can enhance patient safety, mitigate risks, optimize safety team operations, and achieve cost efficiencies.
ArisGlobal Risks and Challenges
In recent year, ArisGlobal has undergone significant leadership transitions, culminating in the appointment of new executives to key positions, including the Chief Executive Officer, Chief Financial Officer, and Chief Technology Officer roles. These strategic leadership changes are anticipated to influence the company's direction, potentially resulting in shifts in organizational strategy and objectives.
ArisGlobal Ecosystem, Partners, Resellers and SI
In October 2023, ArisGlobal inaugurated a new office in Mysore, India, marking a significant expansion effort. Occupying 22,500 square feet within the prestigious Silver Spirit Tech Park, this state-of-the-art facility boasts upgraded workspace amenities and cutting-edge technology infrastructure.
ArisGlobal conducts direct sales operations in the USA, UK, France, Germany, Ireland, Italy, Belgium, India, and Japan. In Japan, ArisGlobal utilizes a channel partner, CTC Laboratory Systems, for sales distribution.
Moreover, ArisGlobal collaborates with renowned vendors such as EMC, IBM, Medidata, and SAP to enhance integration between its Cloud-based solutions and other backend systems, ensuring seamless interoperability for its clients.
ArisGlobal Cloud Infrastructure Insights
Subscribe to read more about:
- ArisGlobal Public Cloud and Infrastructure (IaaS)
- ArisGlobal Platform (PaaS)
- ArisGlobal Application Delivery
- ArisGlobal Private Cloud and Data Centers
Research Methodology
Data used in research reports are derived from publicly available documents, continuous surveys of applications vendors, customers, resellers, Independent Software Vendors, systems integrators and other verifiable sources.
Vendor shares and market forecast results are based on a combination of existing databases as well as demand side and supply side research conducted throughout the year with validation from vendors, customers, channel partners and documentations such as earnings releases and 10Q and 10K filings, vertical industry studies, regional and country-level statistics from public and private institutions(i.e. colleges, universities, government agencies and trade associations).
For additional information on our methodologies, here's the link:
https://www.appsruntheworld.com/About Ushttps://www.appsruntheworld.com/taxonomy
https://www.appsruntheworld.com/FAQ
